Fulcrum Therapeutics, Inc.
2019 Q4 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 653 | 0.0% | 57,725 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 121 | 0.0% | 13,100 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 90 | 0.0% | 13,100 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 38 | 0.0% | 13,100 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 62 | 0.0% | 13,100 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 47 | 0.0% | 13,100 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 156 | 0.0% | 25,100 | 6/30/2024 |
| 2023 Q2 | 10/8/2025 | 1 | 0.0% | 376 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 45 | 0.0% | 15,843 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 136 | 0.0% | 18,664 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 151 | 0.0% | 18,660 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 91 | 0.0% | 18,555 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 440 | 0.0% | 18,601 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 329 | 0.0% | 18,585 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 525 | 0.0% | 18,598 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 130 | 0.0% | 12,410 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 145 | 0.0% | 12,267 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 144 | 0.0% | 12,267 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 97 | 0.0% | 12,267 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 224 | 0.0% | 12,267 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 69 | 0.0% | 5,767 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 96 | 0.0% | 5,767 | 12/31/2019 |